Fred R Hirsch

10PUBLICATIONS

77CO-AUTHORS

Molecular targetsPredictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Jun 03, 2026

Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

|Dec 18, 2025

Small Cell Lung Cancer Classification: Unraveling Heterogeneity to Enable Personalized Treatments.

Kristiina Boettiger, Ildikó Kovács, Lilla Horvath

|Jun 04, 2025

Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non-Small Cell Lung Cancer: A Lung-MAP Study.

Philip C Mack, Mary W Redman, Hanna Tukachinsky

|Apr 28, 2025

Antibody-Drug Conjugates in Non-Small Cell Lung Cancer: Where Are the Target and the Biomarker?

Fred R Hirsch

|Jan 06, 2025

Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions.

Yibei Wang, Mohammed Safi, Fred R Hirsch

|Jul 13, 2024

Calls to action on lung cancer management and research.

May-Lucie Meyer, Fred R Hirsch, Paul A Bunn

Pageof 2

Frequent Collaborators

Philip C Mack

David R Gandara

Hossein Borghaei

David E Kozono

Karen L Reckamp

Mary W Redman

Joel W Neal

Natasha B Leighl

Christian Caglevic

Christian Rolfo

Frequent Collaborators

Philip C Mack

David R Gandara

Hossein Borghaei

David E Kozono